DICE Therapeutics Inc (DICE) Stock Analyst Ratings
USA - NASDAQ:DICE - US23345J1043 - Common Stock
47.55 USD
+0.03 (+0.06%)
47.59 USD
+0.04 (+0.08%)
ChartMill assigns a Buy % Consensus number of 53% to DICE. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 50.36. This target is 5.91% above the current price.
DICE was analyzed by 14 analysts. The buy percentage consensus is at 53. So analysts seem to be rather neutral about DICE.
In the last month the buy percentage fell by 17 points. So the trust of analysts is decreasing.
DICE was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-08-09 | HC Wainwright & Co. | Reiterate | Neutral |
| 2023-06-26 | Needham | Downgrade | Buy -> Hold |
| 2023-06-21 | Canaccord Genuity | Downgrade | Buy -> Hold |
| 2023-06-21 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2023-06-20 | Cantor Fitzgerald | Downgrade | Overweight -> Neutral |
| 2023-06-20 | Wells Fargo | Maintains | Equal-Weight |
| 2023-06-20 | Canaccord Genuity | Downgrade | Buy -> Hold |
| 2023-05-24 | Wells Fargo | Initiate | Equal-Weight |
| 2023-05-22 | Canaccord Genuity | Initiate | Buy |
| 2023-05-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-03-31 | Needham | Reiterate | Buy |
| 2023-03-20 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-16 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-08 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-01 | Cowen & Co. | Initiate | Outperform |
| 2022-11-15 | Guggenheim | Initiate | Buy |
| 2022-10-11 | SVB Leerink | Maintains | Outperform |
| 2022-10-11 | HC Wainwright & Co. | Maintains | Buy |
| 2022-09-14 | Cantor Fitzgerald | Initiate | Overweight |
| 2022-09-07 | Stifel | Initiate | Buy |
| 2022-07-18 | HC Wainwright & Co. | Initiate | Buy |
| 2021-10-11 | B of A Securities | Initiate | Buy |
DICE Therapeutics Inc / DICE FAQ
What do analysts expect the price target to be for DICE Therapeutics Inc (DICE)?
14 analysts have analysed DICE and the average price target is 50.36 USD. This implies a price increase of 5.91% is expected in the next year compared to the current price of 47.55.
How do analysts rate DICE Therapeutics Inc (DICE)?
The consensus rating for DICE Therapeutics Inc (DICE) is 52.8571 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
What is the number of analysts for DICE stock?
The number of analysts covering DICE Therapeutics Inc (DICE) is 14.